Table of Content

Chapter 1 About the Chronic Kidney Disease (CKD) Drugs Industry
1.1 Industry Definition and Types
1.1.1 Hyperphosphatemia; Dietary phosphate binders and dietary phosphate restriction
1.1.2 Hypocalcemia; Calcium supplements and possibly calcitriol
1.1.3 Hyperparathyroidism; Calcitriol or vitamin D analogues
1.1.1.4 Anemia; Iron replacement therapy and erythropoiesis-stimulating agents
1.2 Main Market Activities
1.3 Similar Industries
1.4 Industry at a Glance

Chapter 2 World Market Competition Landscape
2.1 Chronic Kidney Disease (CKD) Drugs Markets by Regions
2.1.1 USA
Market Revenue (M USD) and Growth Rate 2013-2023
Sales and Growth Rate 2013-2023
Major Players Revenue (M USD) in 2017
2.1.2 Europe
Market Revenue (M USD) and Growth Rate 2013-2023
Sales and Growth Rate 2013-2023
Major Players Revenue (M USD) in 2017
2.1.3 China
Market Revenue (M USD) and Growth Rate 2013-2023
Sales and Growth Rate 2013-2023
Major Players Revenue (M USD) in 2017
2.1.4 India
Market Revenue (M USD) and Growth Rate 2013-2023
Sales and Growth Rate 2013-2023
Major Players Revenue (M USD) in 2017
2.1.5 Japan
Market Revenue (M USD) and Growth Rate 2013-2023
Sales and Growth Rate 2013-2023
Major Players Revenue (M USD) in 2017
2.1.6 South East Asia
Market Revenue (M USD) and Growth Rate 2013-2023
Sales and Growth Rate 2013-2023
Major Players Revenue (M USD) in 2017
2.2 World Chronic Kidney Disease (CKD) Drugs Market by Types
Hyperphosphatemia; Dietary phosphate binders and dietary phosphate restriction
Hypocalcemia; Calcium supplements and possibly calcitriol
Hyperparathyroidism; Calcitriol or vitamin D analogues
Anemia; Iron replacement therapy and erythropoiesis-stimulating agents
2.3 World Chronic Kidney Disease (CKD) Drugs Market by Applications
Hospital use
Clinic use
Household
2.4 World Chronic Kidney Disease (CKD) Drugs Market Analysis
2.4.1 World Chronic Kidney Disease (CKD) Drugs Market Revenue and Growth Rate 2013-2017
2.4.2 World Chronic Kidney Disease (CKD) Drugs Market Consumption and Growth rate 2013-2017
2.4.3 World Chronic Kidney Disease (CKD) Drugs Market Price Analysis 2013-2017

Chapter 3 World Chronic Kidney Disease (CKD) Drugs Market share
3.1 Major Production Market share by Players
3.2 Major Revenue (M USD) Market share by Players
3.3 Major Production Market share by Regions in 2017, Through 2023
3.4 Major Revenue (M USD) Market share By Regions in 2017, Through 2023

Chapter 4 Supply Chain Analysis
4.1 Industry Supply chain Analysis
4.2 Raw material Market Analysis
4.2.1 Raw material Prices Analysis 2013-2017
4.2.2 Raw material Supply Market Analysis
4.2 Manufacturing Equipment Suppliers Analysis
4.3 Production Process Analysis
4.4 Production Cost Structure Benchmarks
4.5 End users Market Analysis

Chapter 5 Company Profiles
5.1 Johnson & Johnson
5.1.1 Company Details (Foundation Year, Employee Strength and etc)
5.1.2 Product Information (Picture, Specifications and Applications)
5.1.3 Revenue (M USD), Price and Operating Profits
5.2 Abbott Laboratories
5.2.1 Company Details (Foundation Year, Employee Strength and etc)
5.2.2 Product Information (Picture, Specifications and Applications)
5.2.3 Revenue (M USD), Price and Operating Profits
5.3 F. Hoffmann-La Roche
5.3.1 Company Details (Foundation Year, Employee Strength and etc)
5.3.2 Product Information (Picture, Specifications and Applications)
5.3.3 Revenue (M USD), Price and Operating Profits
5.4 Takeda Pharmaceuticals
5.4.1 Company Details (Foundation Year, Employee Strength and etc)
5.4.2 Product Information (Picture, Specifications and Applications)
5.4.3 Revenue (M USD), Price and Operating Profits
5.5 Actavis
5.5.1 Company Details (Foundation Year, Employee Strength and etc)
5.5.2 Product Information (Picture, Specifications and Applications)
5.5.3 Revenue (M USD), Price and Operating Profits
5.6 Akebia Therapeutic
5.6.1 Company Details (Foundation Year, Employee Strength and etc)
5.6.2 Product Information (Picture, Specifications and Applications)
5.6.3 Revenue (M USD), Price and Operating Profits
5.7 Raptor Pharmaceuticals
5.7.1 Company Details (Foundation Year, Employee Strength and etc)
5.7.2 Product Information (Picture, Specifications and Applications)
5.7.3 Revenue (M USD), Price and Operating Profits
5.8 Rockwell Medical
5.8.1 Company Details (Foundation Year, Employee Strength and etc)
5.8.2 Product Information (Picture, Specifications and Applications)
5.8.3 Revenue (M USD), Price and Operating Profits
5.9 AMAG Pharmaceuticals
5.9.1 Company Details (Foundation Year, Employee Strength and etc)
5.9.2 Product Information (Picture, Specifications and Applications)
5.9.3 Revenue (M USD), Price and Operating Profits
5.10 Sanofi
5.10.1 Company Details (Foundation Year, Employee Strength and etc)
5.10.2 Product Information (Picture, Specifications and Applications)
5.10.3 Revenue (M USD), Price and Operating Profits
5.11 Reata Pharmaceuticals
5.11.1 Company Details (Foundation Year, Employee Strength and etc)
5.11.2 Product Information (Picture, Specifications and Applications)
5.11.3 Revenue (M USD), Price and Operating Profits
5.12 Cara Therapeutics
5.12.1 Company Details (Foundation Year, Employee Strength and etc)
5.12.2 Product Information (Picture, Specifications and Applications)
5.12.3 Revenue (M USD), Price and Operating Profits
5.13 FibroGen
5.13.1 Company Details (Foundation Year, Employee Strength and etc)
5.13.2 Product Information (Picture, Specifications and Applications)
5.13.3 Revenue (M USD), Price and Operating Profits

Chapter 6 Globalisation & Trade
6.1 Business Locations
6.2 Supply channels
6.3 Marketing strategy
6.4 Barriers to Entry

Chapter 7 Distributors and Customers
7.1 Major Distributors and contact information by Regions
7.2 Major Customers and contact information by Regions

Chapter 8 Import, Export, Consumption and Consumption Value by Major Countries
8.1 USA
8.2 Germany
8.3 China
8.4 Japan
8.5 India

Chapter 9 World Chronic Kidney Disease (CKD) Drugs Market Forecast through 2023
9.1 World Chronic Kidney Disease (CKD) Drugs Demand by Regions Forecast through 2023
9.2 World Chronic Kidney Disease (CKD) Drugs Price(by Regions, Types, Applications)Analysis Forecast through 2023
9.3 World Chronic Kidney Disease (CKD) Drugs Revenue (M USD)(by Regions, Types, Applications) Forecast through 2023
9.4 World Chronic Kidney Disease (CKD) Drugs Market Analysis
9.4.1 World Chronic Kidney Disease (CKD) Drugs Market Revenue and Growth Rate 2013-2017
9.4.2 World Chronic Kidney Disease (CKD) Drugs Market Consumption and Growth rate 2013-2017
9.4.3 World Chronic Kidney Disease (CKD) Drugs Market Price Analysis 2013-2017

Chapter 10 Key success factors and Market Overview

Tables and figures
Table Main Market Activities by Regions
Table Market Revenue (M USD) and Growth Rate 2013-2023
Table Major Players Revenue (M USD) in 2017
Table Market Revenue (M USD) and Growth Rate 2013-2023
Table Major Players Revenue (M USD) in 2017
Table Market Revenue (M USD) and Growth Rate 2013-2023
Table Major Players Revenue (M USD) in 2017
Table Market Revenue (M USD) and Growth Rate 2013-2023
Table Major Players Revenue (M USD) in 2017
Table Market Revenue (M USD) and Growth Rate 2013-2023
Table Major Players Revenue (M USD) in 2017
Table Major Production Market share by Players 2017
Table Major Revenue (M USD) Market share by Players 2017
Table Production Market share by Major Regions in 2013-2017
Table Production Market share by Major Regions in 2017-2023
Table Revenue (M USD) Market share by Regions in 2013-2017
Table Revenue (M USD) Market share by Regions in 2017-2023
Table Industry Supply chain Analysis
Table Raw material Prices Analysis 2013-2017
Table Raw material Suppliers Market Analysis
Table Manufacturing Equipment Suppliers Analysis
Figure Production Process Analysis
Figure Production Cost Structure
Table major End Users by Regions
Table Johnson & Johnson Information List
Figure Chronic Kidney Disease (CKD) DrugsChronic Kidney Disease (CKD) Drugs Picture, Specifications and Applications of Johnson & Johnson
Table Chronic Kidney Disease (CKD) Drugs Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Johnson & Johnson 2017-2017
Figure Chronic Kidney Disease (CKD) Drugs Sales Volume and World Market Share of Johnson & Johnson 2017-2017
Table Abbott Laboratories Information List
Figure Chronic Kidney Disease (CKD) Drugs Picture, Specifications and Applications of Abbott Laboratories
Table Chronic Kidney Disease (CKD) Drugs Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Abbott Laboratories 2017-2017
Figure Chronic Kidney Disease (CKD) Drugs Sales Volume and World Market Share of Abbott Laboratories 2017-2017
Table F. Hoffmann-La Roche Information List
Figure Chronic Kidney Disease (CKD) Drugs Picture, Specifications and Applications of F. Hoffmann-La Roche
Table Chronic Kidney Disease (CKD) Drugs Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of F. Hoffmann-La Roche 2017-2017
Figure Chronic Kidney Disease (CKD) Drugs Sales Volume and World Market Share of F. Hoffmann-La Roche 2017-2017
Table Takeda Pharmaceuticals Information List
Figure Chronic Kidney Disease (CKD) Drugs Picture, Specifications and Applications of Takeda Pharmaceuticals
Table Chronic Kidney Disease (CKD) Drugs Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Takeda Pharmaceuticals 2017-2017
Figure Chronic Kidney Disease (CKD) Drugs Sales Volume and World Market Share of Takeda Pharmaceuticals 2017-2017
Table Actavis Information List
Figure Chronic Kidney Disease (CKD) Drugs Picture, Specifications and Applications of Actavis
Table Chronic Kidney Disease (CKD) Drugs Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Actavis 2017-2017
Figure Chronic Kidney Disease (CKD) Drugs Sales Volume and World Market Share of Actavis 2017-2017
Table Akebia Therapeutic Information List
Figure Chronic Kidney Disease (CKD) Drugs Picture, Specifications and Applications of Akebia Therapeutic
Table Chronic Kidney Disease (CKD) Drugs Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Akebia Therapeutic 2017-2017
Figure Chronic Kidney Disease (CKD) Drugs Sales Volume and World Market Share of Akebia Therapeutic 2017-2017
Table Raptor Pharmaceuticals Information List
Figure Chronic Kidney Disease (CKD) Drugs Picture, Specifications and Applications of Raptor Pharmaceuticals
Table Chronic Kidney Disease (CKD) Drugs Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Raptor Pharmaceuticals 2017-2017
Figure Chronic Kidney Disease (CKD) Drugs Sales Volume and World Market Share of Raptor Pharmaceuticals 2017-2017
Table Rockwell Medical Information List
Figure Chronic Kidney Disease (CKD) Drugs Picture, Specifications and Applications of Rockwell Medical
Table Chronic Kidney Disease (CKD) Drugs Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Rockwell Medical 2017-2017
Figure Chronic Kidney Disease (CKD) Drugs Sales Volume and World Market Share of Rockwell Medical 2017-2017
Table AMAG Pharmaceuticals Information List
Figure Chronic Kidney Disease (CKD) Drugs Picture, Specifications and Applications of AMAG Pharmaceuticals
Table Chronic Kidney Disease (CKD) Drugs Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of AMAG Pharmaceuticals 2017-2017
Figure Chronic Kidney Disease (CKD) Drugs Sales Volume and World Market Share of AMAG Pharmaceuticals 2017-2017
Table Sanofi Information List
Figure Chronic Kidney Disease (CKD) Drugs Picture, Specifications and Applications of Sanofi
Table Chronic Kidney Disease (CKD) Drugs Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Sanofi 2017-2017
Figure Chronic Kidney Disease (CKD) Drugs Sales Volume and World Market Share of Sanofi 2017-2017
Table Reata Pharmaceuticals Information List
Figure Chronic Kidney Disease (CKD) Drugs Picture, Specifications and Applications of Reata Pharmaceuticals
Table Chronic Kidney Disease (CKD) Drugs Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Reata Pharmaceuticals 2017-2017
Figure Chronic Kidney Disease (CKD) Drugs Sales Volume and World Market Share of Reata Pharmaceuticals 2017-2017
Table Cara Therapeutics Information List
Figure Chronic Kidney Disease (CKD) Drugs Picture, Specifications and Applications of Cara Therapeutics
Table Chronic Kidney Disease (CKD) Drugs Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of Cara Therapeutics 2017-2017
Figure Chronic Kidney Disease (CKD) Drugs Sales Volume and World Market Share of Cara Therapeutics 2017-2017
Table FibroGen Information List
Figure Chronic Kidney Disease (CKD) Drugs Picture, Specifications and Applications of FibroGen
Table Chronic Kidney Disease (CKD) Drugs Sales Volume, Price, Operating Cost, Operating Profits, Revenue (M USD) and Profits Margin of FibroGen 2017-2017
Figure Chronic Kidney Disease (CKD) Drugs Sales Volume and World Market Share of FibroGen 2017-2017
Table Business Locations
Figure Supply channels
Figure Marketing strategy
Table Barriers Analysis to Entry
Table Major Distributors and contact information by Regions
Table Major Customers and contact information by Regions
Table USA Supply, Import, Export, Consumption and Consumption Value(M USD)
Table Germany Supply, Import, Export, Consumption and Consumption Value(M USD)
Table China Supply, Import, Export, Consumption and Consumption Value(M USD)
Table Japan Supply, Import, Export, Consumption and Consumption Value(M USD)
Table India Supply, Import, Export, Consumption and Consumption Value(M USD)
Table World Demand by Regions Forecast Analysis of Chronic Kidney Disease (CKD) Drugs (2017-2023)
Table World Price by Regions Forecast Analysis of Chronic Kidney Disease (CKD) Drugs (2017-2023)
Table World Price by Types Forecast Analysis of Chronic Kidney Disease (CKD) Drugs (2017-2023)
Table World Price by Applications Forecast Analysis of Chronic Kidney Disease (CKD) Drugs (2017-2023)
Table World Revenue (M USD) by Regions Forecast Analysis of Chronic Kidney Disease (CKD) Drugs (2017-2023)
Table World Revenue (M USD) by Types Forecast Analysis of Chronic Kidney Disease (CKD) Drugs (2017-2023)
Table World Revenue (M USD) by Applications Forecast Analysis of Chronic Kidney Disease (CKD) Drugs (2017-2023)